Payload Information
General Information of This Payload
| Payload ID | PAY0DTXLU |
|||||
|---|---|---|---|---|---|---|
| Name | FD7 |
|||||
| Synonyms |
FD7
Click to Show/Hide
|
|||||
| Target | DNA topoisomerase I (TOP1) | |||||
| Structure |
|
|||||
| Formula | C26H27FN4O4 |
|||||
| Isosmiles | CC[C@]1(O)C(C=C2C3=NC4=CC(F)=C(N)C=C4C(CN5CCCCC5)=C3CN62)=C(COC1=O)C6=O |
|||||
| PubChem CID | ||||||
| InChI |
InChI=1S/C26H27FN4O4/c1-2-26(34)18-9-22-23-16(12-31(22)24(32)17(18)13-35-25(26)33)15(11-30-6-4-3-5-7-30)14-8-20(28)19(27)10-21(14)29-23/h8-10,34H,2-7,11-13,28H2,1H3/t26-/m0/s1
|
|||||
| InChIKey |
OHWRBAMYYKSMGR-SANMLTNESA-N
|
|||||
| Pharmaceutical Properties | Molecule Weight |
478.524 |
Polar area |
110.68 |
||
Complexity |
1419.139497 |
xlogp Value |
2.7868 |
|||
Heavy Count |
35 |
Rot Bonds |
3 |
|||
Hbond acc |
8 |
Hbond Donor |
2 |
|||
The activity data of This Payload
Each Antibody-drug Conjugate Related to This Payload
Full Information of The Activity Data of The ADC(s) Related to This Payload
38354417 T-DL14 [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
2.9 nM
|
High HER2 expression (HER2 +++) | ||
| Method Description |
A total of 30,000 SK-BR-3 (HER2-high) cells were seeded either as monocultures or cocultures in TC-treated 48-well microtiter plates (Greiner Bio-One, catalog no. 667180) and treated with 1.0 or 0.1 nmol/L ADCs diluted in growth medium.
|
||||
| In Vitro Model | Breast adenocarcinoma | SK-BR-3 cells | CVCL_0033 | ||
| Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 30 nM | Negative HER2 expression (HER2-) | ||
| Method Description |
A total of 10,000 MDA-MB-468 (HER2-negative) cells were seeded either as monocultures or cocultures in TC-treated 48-well microtiter plates (Greiner Bio-One, catalog no. 667180) and treated with 1.0 or 0.1 nmol/L ADCs diluted in growth medium.
|
||||
| In Vitro Model | Breast adenocarcinoma | MDA-MB-468 cells | CVCL_0419 | ||
References